The Lesjöfors Group’s manufacturing plant in Changzhou, China, has passed the certification process for ISO 13485 - the medical industry's optimal medical device standard.
Global market leaders in spring and pressing manufacture, Lesjöfors China is now officially recognized as meeting the vigilant regulatory compliance laws and exceptional high demands of its medical customers.
Medical futures
The medical industry is constantly evolving and growing, partly due to an aging population. Innovations in drug delivery devices and diagnosis are not only improving a generation’s quality of life, but also enabling individuals to self-monitor and self-medicate.
Crucially sitting at the heart of many of these devices, and performing a vital function within the device application, are springs and pressings.
Mikael Andersson, VP Lesjöfors Asia says: “Lesjöfors is one of the largest global suppliers of springs and pressings to the medical sector and this recent certification in China takes us one step closer to achieving our strategic growth goals. Our ambition is to not only become the largest supplier but also to be seen as the preferred supplier of springs and pressings to the global medical industry.
We recognize that market growth for medical devices is stronger in Asia than in Europe and USA. Achieving the ISO 13485 medical certification is a comprehensive quality certification of our quality and manufacturing processes, enabling our China operation to be increasingly confident within the marketplace.”
Global procurement solutions
The medical sector is known for developing projects worldwide, sourcing from a bank of global suppliers. Lesjöfors’ global footprint, with spring and pressing manufacture operations across Asia, America and Europe, offers a one-stop-shop supply partner to meet the demands of the international medical marketplace.
Andersson continues: “We appreciate companies have different sourcing strategies. We want to simplify procurement. Lesjöfors’ global sales and manufacturing platform enables our customers to avoid supply chain risks as we’re geographically positioned to offer efficiencies. Our network of operations delivers a ‘local’ supply chain, reducing lead time risks within the purchasing cycle.”
Lesjöfors’s China operation plays a significant role across Asia, not only in production for the Chinese market but also across global projects and exports. Lesjöfors’s company in Singapore is also certified to ISO 13485, enhancing the opportunities for the medical sector customer base.
Growth potential in Lesjöfors in Changzhou
Lesjöfors China has grown due to a recent production move from Shanghai into the Changzhou facilities. Production scope has expanded, with new capabilities including torsion springs, wire forms, extension springs and clock springs, in smaller wire sizes. This is in addition to compression springs, up to 8 mm, and stampings up to 200T.
Number one for sustainability
In a first for the spring manufacturing industry, the Lesjöfors Group’s near-term climate emission reduction targets have officially been validated by the Science Based Target Initiative (SBTi).
“We’re receiving an increasing number of enquiries from our customers concerning our sustainable values and it’s fantastic that we can respond to these needs,” concludes Andersson.
The Lesjöfors Group’s position within the global medical sector is looking very healthy and with the recent ISO certification in China and SBTi validation, it is looking to get even healthier.
